Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Circulatory system drugs >  Antiarrhythmics Drugs >  Tocainide hydrochloride

Tocainide hydrochloride

Basic information Safety Supplier Related

Tocainide hydrochloride Basic information

Product Name:
Tocainide hydrochloride
Synonyms:
  • 2-amino-n-(2,6-dimethylphenyl)propanamide hydrochloride
  • tocainide hydrochloride
  • 2-amino-n-(2,6-dimethylphenyl)propanamidemonohydrochloride
  • 2-amino-n-(2,6-dimethylphenyl)-propanamidmonohydrochloride
  • tonocardhydrochloride
  • TOCAINIDE HCL
  • Propanamide, 2-amino-N-(2,6-dimethylphenyl)-, monohydrochloride
  • Unii-2K7I38ckn5
CAS:
35891-93-1
MF:
C11H17ClN2O
MW:
228.71848
Mol File:
35891-93-1.mol
More
Less

Tocainide hydrochloride Chemical Properties

Melting point:
244-245°C
storage temp. 
-20°C Freezer
solubility 
Methanol (Slightly), Water (Slightly)
form 
Solid
color 
Off-White
More
Less

Safety Information

HS Code 
2924296000
More
Less

Tocainide hydrochloride Usage And Synthesis

Uses

Tonocard(AstraZeneca).

Uses

Tocainide Hydrochloride is used as an anti-arrythmic drug as myocardial depressants.

General Description

Tocainide hydrochloride,2-amino-2' ,6 '-propionoxyxylidide hydrochloride (Tonocard)(pKa 7.7), is an analog of lidocaine. It is orally active and haselectrophysiological properties like those of lidocaine. Totalbody clearance of tocainide hydrochloride is only166 mL/min, suggesting that hepatic clearance is not large.Because of low hepatic clearance, the hepatic extraction ratiomust be small; therefore, tocainide hydrochloride is unlikelyto be subject to a substantial first-pass effect. The drug differsfrom lidocaine, in that it lacks two ethyl groups, which providestocainide hydrochloride some protection from first-passhepatic elimination after oral ingestion. Tocainide hydrochlorideis hydrolyzed in a manner similar to that of lidocaine.None of its metabolites is active.

Clinical Use

Tocainide hydrochloride is classed as a IB antiarrhythmicagent and used orally to prevent or treat ventricular ectopyand tachycardia. The drug is given in 400- to 600-mgdoses every 8 hours.

Veterinary Drugs and Treatments

Veterinary experience with tocainide is limited. At this time, dogs are the only veterinary species where enough clinical experience has been garnered to recommend its use. It is indicated for the oral therapy of ventricular arrhythmias, principally ventricular tachycardia and ventricular premature complexes. In humans, response to lidocaine can usually predict whether tocainide might be effective.

Tocainide hydrochlorideSupplier

Shanxi New Baoyuan Pharmaceutical Co., Ltd. Gold
Tel
0352-7606558
Email
zhaoshujun@xinbaoyuanpharm.com
Sinopharm Chemical Reagent Co,Ltd.
Tel
86-21-63210123
Email
sj_scrc@sinopharm.com
Boen pharm
Tel
86 512-62572107 62962707
Shanghai Chaolan Chemical Technology Center
Tel
021-QQ:65489617 15618227136
Email
Sales@ATKchemical.com
Beijing Solarbio Science & Tecnology Co., Ltd.
Tel
010-50973186 4009686088
Email
3193328036@qq.com